News News Select Year All Years 2026 (31) 2025 (34) 2024 (29) 2023 (30) 2022 (33) 2021 (27) 2020 (34) 2019 (32) 2018 (42) 2017 (35) 2016 (43) 2015 (53) 2014 (26) 2013 (21) 2012 (16) 2011 (6) 2010 (4) 2009 (5) 2007 (1) 2006 (1) Search News Found 503 Results Page 43 of 51« First«...102030...4142434445...50...»Last » January 14, 2015 Half year update on the DBV Technologies liquidity agreement January 12, 2015 DBV Technologies Announces Publication in the Journal of Allergy and Clinical Immunology of Data Demonstrating that Epicutaneous Immunotherapy may Influence the Natural History of Allergy January 8, 2015 DBV Technologies Provides Organizational Update November 20, 2014 DBV Technologies Initiates Phase I/II Clinical Trial with Viaskin Milk for the Treatment of Children with Cow’s Milk Allergy October 23, 2014 Global offering of DBV Technologies ordinary shares October 22, 2014 DBV Technologies S.A. Announces Pricing of Global Offering October 20, 2014 DBV Technologies S.A. Announces Proposed Global Offering October 14, 2014 DBV Technologies Announces Topline Financial Results for First Nine Months 2014 September 22, 2014 DBV Technologies Announces Primary Endpoint Met in VIPES, Viaskin Peanut’s Phase IIb Clinical Trial in Peanut Allergy August 26, 2014 DBV Technologies to Attend the Goldman Sachs European Biotech Symposium Page 43 of 51« First«...102030...4142434445...50...»Last »